1. |
施惠宣, 陈国兵, 陈先睿. 川崎病合并 G6PD 缺乏症 1 例并文献复习. 临床荟萃, 2020, 35(6): 555-557.
|
2. |
Dimitriades VR, Brown AG, Gedalia A. Kawasaki disease: pathophysiology, clinical manifestations and management. Curr Rheumatol Rep, 2014, 16(6): 423.
|
3. |
石晓青, 李一飞, 华益民, 等. 基于多元统计和社会网络分析我国川崎病诊疗现状的可视化研究. 中华妇幼临床医学杂志 (电子版), 2013, 9(6): 723-729.
|
4. |
Lo MS. A framework for understanding Kawasaki disease pathogenesis. Clin Immunol, 2020, 214: 108385.
|
5. |
Riphagen S, Gomez X, Gonzalez-Martinez C, et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet, 2020, 395(10237): 1607-1608.
|
6. |
Chen Chaomei. CiteSpace Ⅱ: detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inf Sci Technol, 2006, 57(3): 359-377.
|
7. |
贾路, 张云军, 胡英化. 近 10 年包虫病研究的文献计量学分析. 预防医学情报杂志, 2013, 29(12): 1103-1105.
|
8. |
Liang C, Luo A, Zhong Z. Knowledge mapping of medication literacy study: a visualized analysis using CiteSpace. SAGE Open Med, 2018, 6: 2050312118800199.
|
9. |
叶佳美, 胡晓敏, 王丽群, 等. 间充质干细胞治疗脊髓损伤的可视化分析. 中国康复理论与实践, 2020, 26(4): 400-406.
|
10. |
McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation, 2017, 135(17): e927-e999.
|
11. |
Kobayashi T, Saji T, Otani T, et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet, 2012, 379(9826): 1613-1620.
|
12. |
Uehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol, 2012, 22(2): 79-85.
|
13. |
Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet, 2020, 395(10239): 1771-1778.
|
14. |
Whittaker E, Bamford A, Kenny J, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA, 2020, 324(3): 259-269.
|
15. |
Onouchi Y, Gunji T, Burns JC, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet, 2008, 40(1): 35-42.
|
16. |
王志娟, 毕琳, 姜桐桐, 等. 基于 CiteSpace Ⅲ的我国产科护理相关文献的计量学分析. 护理研究, 2018, 32(13): 2066-2070.
|